ImmuCell Corporation (ICCC) vs Korro Bio, Inc. (KRRO)
A side-by-side comparison of ImmuCell Corporation and Korro Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ICCC
ImmuCell Corporation
$9.80HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
KRRO
Korro Bio, Inc.
$9.81HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
Total return — ICCC vs KRRO
growth of $100 · dividends reinvested · last 7yICCC +85.7% (+9.2%/yr)KRRO -98.5% (-45.4%/yr)ICCC compounded faster over this window
Log scale — wide-divergence pair
ICCC KRRO
ICCC vs KRRO: by the numbers
- •KRRO is the larger company ($98M vs $89M market cap).
- •ICCC is profitable (2.57% net margin) while KRRO runs a net loss (-4477.08%).
- •ICCC grew revenue faster over the past five years (13.74% vs -41.67% CAGR).
Metrics side by side
Valuation
| Metric | ICCC | KRRO |
|---|---|---|
| P/E ratio | 115.84 | N/A |
| P/S ratio | 2.89 | 40.99 |
| P/B ratio | 2.83 | 0.95 |
| EV / EBITDA | 14.76 | N/A |
| FCF yield | 4.75% | N/A |
Profitability
| Metric | ICCC | KRRO |
|---|---|---|
| Gross margin | 40.32% | 33.04% |
| Operating margin | 12.60% | -1366.43% |
| Net margin | 2.57% | -4477.08% |
| ROE | 2.51% | -103.31% |
| ROIC | 8.16% | -50.17% |
Growth (annualized)
| Metric | ICCC | KRRO |
|---|---|---|
| Revenue CAGR (5Y) | 13.74% | -41.67% |
| Total return CAGR (5Y) | 0.65% | -50.72% |
Frequently asked
- Which has grown faster, ICCC or KRRO?
- Over the past five years, ICCC grew revenue faster — ICCC at a 13.74% CAGR versus KRRO at -41.67%.
- Is ICCC or KRRO more profitable?
- ICCC runs the higher net margin — ICCC at 2.57% versus KRRO at -4477.08%.
- How have ICCC and KRRO total returns compared?
- Over the past 5 years, ICCC delivered 0.65% and KRRO delivered -50.72% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ImmuCell P/E ratioImmuCell ROEKorro Bio ROEImmuCell operating marginKorro Bio operating marginImmuCell revenue growthKorro Bio revenue growthImmuCell free cash flowKorro Bio free cash flow
ImmuCell & Korro Bio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.